{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:28:47Z","timestamp":1786717727183,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0253-7613.174388","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:42Z","timestamp":1467158442000},"page":"4","source":"Crossref","is-referenced-by-count":39,"title":["Metformin - For the dermatologist"],"prefix":"10.4103","volume":"48","author":[{"given":"AdityaKumar","family":"Bubna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.174388-1","first-page":"820","volume-title":"Metformin pathways: Pharmacokinetics and pharmacodynamics","author":"Gong","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"key-10.4103\/0253-7613.174388-2","first-page":"81","volume-title":"Clinical pharmacokinetics of metformin","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"key-10.4103\/0253-7613.174388-3","first-page":"239","volume-title":"An approach to acanthosis nigricans","author":"Phiske","year":"2014","journal-title":"Indian Dermatol Online J","ISSN":"https:\/\/id.crossref.org\/issn\/2229-5178","issn-type":"print"},{"key":"key-10.4103\/0253-7613.174388-4","first-page":"199","volume-title":"Acanthosis nigricans associated with insulin resistance: Pathophysiology and management","author":"Hermanns-L\u00ea","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"key-10.4103\/0253-7613.174388-5","first-page":"677","volume-title":"Improvement of acanthosis nigricans on isotretinoin and metformin","author":"Walling","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0253-7613.174388-6","first-page":"793","volume-title":"Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome","author":"Jensterle","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0253-7613.174388-7","first-page":"339","volume-title":"Use of metformin in obese adolescents with hyperinsulinemia: A 6-month, randomized, double-blind, placebo-controlled clinical trial","author":"Atabek","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key-10.4103\/0253-7613.174388-8","first-page":"97","volume-title":"Association of acanthosis nigricans and skin tags with insulin resistance","author":"Barbato","year":"2012","journal-title":"An Bras Dermatol"},{"key":"key-10.4103\/0253-7613.174388-9","first-page":"194","volume-title":"Metformin plus low dose glimepiride significantly improves homeostasis model assessment for insulin resistance (HOMA(IR)) and beta-cell function HOMA(beta-cell) without hyperinsulinemia in patients with type-2 diabetes mellitus","author":"Bermudez-Pirila","year":"2007","journal-title":"Am J Ther"},{"key":"key-10.4103\/0253-7613.174388-10","first-page":"884","volume-title":"Comparison of metformin versus rosiglitazone in patients with acanthosis nigricans: A pilot study","author":"Bellot-Rojas","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"key-10.4103\/0253-7613.174388-11","first-page":"12","volume-title":"Juvenile acanthosis nigricans and insulin resistance","author":"Hermanns-L\u00ea","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/0253-7613.174388-12","first-page":"990","volume-title":"Correlation of facial sebum to serum insulin-like growth factor-1 in patients with acne","author":"Vora","year":"2008","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0253-7613.174388-13","first-page":"1389","volume-title":"Relationship between the growth hormone\/insulin-like growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls","author":"Guercio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0253-7613.174388-14","first-page":"7329","volume-title":"Insulin like growth factor 1\/insulin signalling activates androgen signalling through direct interactions of Foxo 1 with androgen receptor","author":"Fan","year":"2007","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0253-7613.174388-15","first-page":"E38","volume-title":"Transcriptional regulation of the insulin responsive glucose transporter GLUT 4 gene: From physiology to pathology","author":"Karnilli","year":"2008","journal-title":"Am J Physiol Endocrinol Metabol"},{"key":"key-10.4103\/0253-7613.174388-16","first-page":"669","volume-title":"Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance","author":"Tan","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0253-7613.174388-17","first-page":"3361","volume-title":"Treatment of androgen excess in adolescent girls: Ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide- metformin","author":"Ib\u00e1\u00f1ez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0253-7613.174388-18","doi-asserted-by":"crossref","unstructured":"Belisle ES, Park HY. Metformin: A potential drug to treat hyperpigmentation disorders. J Invest Dermatol 2014;134:2488-91.","DOI":"10.1038\/jid.2014.245"},{"key":"key-10.4103\/0253-7613.174388-19","first-page":"159","volume-title":"Topical application of a protein kinase C inhibitor reduces skin and hair pigmentation","author":"Park","year":"2004","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0253-7613.174388-20","first-page":"156","volume-title":"Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P) H oxidase pathway in human aortic endothelial cells","author":"Batchuluun","year":"2014","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0253-7613.174388-21","first-page":"2589","volume-title":"Inhibition of melanogenesis by the antidiabetic metformin","author":"Lehraiki","year":"2014","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/0253-7613.174388-22","first-page":"834","volume-title":"65-year-old man with yellow-orange papules on both forearms.Eruptive xanthomas","author":"Streit","year":"2009","journal-title":"Hautarzt"},{"key":"key-10.4103\/0253-7613.174388-23","first-page":"1034","volume-title":"Preliminary findings suggest hidradenitis suppurativa maybe due to defective follicular support","author":"Danby","year":"2013","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/0253-7613.174388-24","first-page":"1101","volume-title":"Metformin for the treatment of hidradenitis suppurativa: A little help along the way","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0253-7613.174388-25","first-page":"920","volume-title":"Long-standing hidradenitis suppurativa treated effectively with metformin","author":"Arun","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/0253-7613.174388-26","first-page":"217","volume-title":"The effect of metformin on hirsutism in polycystic ovary syndrome","author":"Kelly","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/0253-7613.174388-27","first-page":"E1262","volume-title":"Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence","author":"Ib\u00e1\u00f1ez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/0253-7613.174388-28","first-page":"231","volume-title":"Increased insulin sensitivity by metformin enhances intense-pulsed-light-assisted hair removal in patients with polycystic ovary syndrome","author":"Rezvanian","year":"2009","journal-title":"Dermatology"},{"key":"key-10.4103\/0253-7613.174388-29","first-page":"252","volume-title":"A marriage of two \"Methusalem\" drugs for the treatment of psoriasis.Arguments for a pilot trial with metformin as add-on for methotrexate?","author":"Glossmann","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"key-10.4103\/0253-7613.174388-30","first-page":"4827","volume-title":"Mitochondrial reactive oxygen species control T cell activation by regulating IL-2 and IL-4 expression: Mechanism of ciprofloxacin-mediated immunosuppression","author":"Kaminski","year":"2010","journal-title":"J Immunol"},{"key":"key-10.4103\/0253-7613.174388-31","first-page":"1016","volume-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","author":"Mihaylova","year":"2011","journal-title":"Nat Cell Biol"},{"key":"key-10.4103\/0253-7613.174388-32","first-page":"248","volume-title":"Metformin ameliorates methotrexate-induced hepatotoxicity","author":"Hadi","year":"2012","journal-title":"J Pharmacol Pharmacother","ISSN":"https:\/\/id.crossref.org\/issn\/0976-500X","issn-type":"print"},{"key":"key-10.4103\/0253-7613.174388-33","first-page":"345","volume-title":"Therapeutic potential of the anti-diabetic agent metformin in targeting the skin cancer stem cell diaspora","author":"Reddi","year":"2014","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/0253-7613.174388-34","first-page":"1374","volume-title":"Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation","author":"Sikka","year":"2012","journal-title":"Cell Cycle"},{"key":"key-10.4103\/0253-7613.174388-35","first-page":"1605","volume-title":"Metformin blocks melanoma invasion and metastasis development in AMPK\/p53-dependent manner","author":"Cerezo","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"key-10.4103\/0253-7613.174388-36","first-page":"1149","volume-title":"Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway","author":"Chaudhary","year":"2012","journal-title":"Photochem Photobiol"},{"key":"key-10.4103\/0253-7613.174388-37","first-page":"1397","volume-title":"Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion","author":"Iliopoulos","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0253-7613.174388-38","first-page":"972","volume-title":"Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth","author":"Hirsch","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0253-7613.174388-39","first-page":"3196","volume-title":"Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types","author":"Iliopoulos","year":"2011","journal-title":"Cancer Res"},{"key":"key-10.4103\/0253-7613.174388-40","first-page":"344","volume-title":"Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A","author":"Martin","year":"2012","journal-title":"Cancer Discov"},{"key":"key-10.4103\/0253-7613.174388-41","first-page":"4","volume-title":"Contraindications to the use of metformin","author":"Jones","year":"2003","journal-title":"BMJ"},{"key":"key-10.4103\/0253-7613.174388-42","unstructured":"Powers AC, D\u2032Alessio D. Endocrine pancreas and pharmacotherapy of diabetes mellitus and hypoglycaemia. In: Brunton L, Chabner B, Knollman B, editors. Goodman and Gilman\u2032s The Pharmacological Basis of Therapeutics. 12 th ed. New York: McGraw Hill; 2011. p. 1237-73."},{"key":"key-10.4103\/0253-7613.174388-43","first-page":"157","volume-title":"Metformin therapy and clinical uses","author":"Scarpello","year":"2008","journal-title":"Diab Vasc Dis Res"},{"key":"key-10.4103\/0253-7613.174388-44","first-page":"249","volume-title":"Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin","author":"Skandalis","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/0253-7613.174388-45","first-page":"376","volume-title":"Lichen planus associated with metformin therapy","author":"Azzam","year":"1997","journal-title":"Dermatology"},{"key":"key-10.4103\/0253-7613.174388-46","first-page":"61","volume-title":"Metformin-induced leukocytoclastic vasculitis: A case report","author":"Czarnowicki","year":"2012","journal-title":"Am J Clin Dermatol"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:27:44Z","timestamp":1786714064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.174388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"alternative-id":["174388"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.174388","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}